Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27921700 | 0.88 | ALDH1A1 (0.31) | ALDH1A1PKM | |
| Nitric Acid SCHEMBL27921689 | 0.86 | ALDH1A1 (0.31) | ALDH1A1PKM | |
| Hydrochloric Acid SCHEMBL2229191 | 0.86 | MAPT (0.34) | ALDH1A1PKM | |
| SCHEMBL28176782 | 0.86 | MAPT (0.42) | ALDH1A1PKM | |
| Bromide SCHEMBL9547368 | 0.83 | MAPT (0.40) | — | |
| SCHEMBL28204342 | 0.80 | MAPT (0.31) | — | |
| SCHEMBL28179977 | 0.78 | ALDH1A1 (0.39) | ALDH1A1PKMPOLBSMN1; SMN2 | |
| Bromide SCHEMBL3854365 | 0.78 | — | — | |
| SCHEMBL28841371 | 0.78 | ALDH1A1 (0.39) | ALDH1A1PKMPOLBSMN1; SMN2 | |
| SCHEMBL28608551 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE48165-E1 | Alkenyl (perfluoroalkyl) phosphinic acids | MERCK PATENT GMBH (DE) | 2020-08-18 | — | — | US | disclosed |
| CN-107074890-B | Alkenyl (perfluoroalkyl) phosphinic acids | 默克专利股份公司 | 2019-09-24 | — | — | CN | disclosed |
| CN-107200787-B | A kind of imidazoles alginate ionic liquid and its synthetic method | 四川大学 | 2019-08-13 | — | — | CN | disclosed |
| US-10160777-B2 | Alkenyl(perfluoroalkyl)phosphinic acids | MERCK PATENT GMBH (DE) | 2018-12-25 | — | — | US | disclosed |
| EP-3207047-B1 | ALKENYL (PERFLUOROALKYL) PHOSPHINIC ACID | MERCK PATENT GMBH (DE) | 2018-09-12 | — | — | EP | disclosed |
| CN-107200787-A | A kind of imidazoles alginate ionic liquid and its synthetic method | 四川大学 | 2017-09-26 | — | — | CN | disclosed |
| US-20170240574-A1 | ALKENYL (PERFLUOROALKYL) PHOSPHINIC ACIDS | MERCK PATENT GMBH (DE) | 2017-08-24 | — | — | US | disclosed |
| EP-3207047-A1 | ALKENYL (PERFLUOROALKYL) PHOSPHINIC ACID | Merck Patent GmbH (DE) | 2017-08-23 | — | — | EP | disclosed |
| CN-107074890-A | Alkenyl (perfluoroalkyl) phosphinic acids | 默克专利股份公司 | 2017-08-18 | — | — | CN | disclosed |
| WO-2016058668-A1 | ALKENYL (PERFLUOROALKYL) PHOSPHINIC ACID | MERCK PATENT GMBH (DE) | 2016-04-21 | — | — | WO | disclosed |
| EP-2621939-B1 | FUNCTIONALIZED FLUOROALKYL FLUOROPHOSPHATE SALTS | MERCK PATENT GMBH (DE) | 2015-06-10 | — | — | EP | disclosed |
| WO-2015049034-A1 | PERFLUOROALKYL FLUORO- OR PERFLUOROALKYL CHLOROGERMANATES | MERCK PATENT GMBH (DE) | 2015-04-09 | — | — | WO | disclosed |
| WO-2015022048-A1 | HEXACYANODIBORATES | MERCK PATENT GMBH (DE) | 2015-02-19 | — | — | WO | disclosed |
| US-8846922-B2 | Functionalized fluoroalkyl fluorophosphate salts | MERCK PATENT GMBH (DE) | 2014-09-30 | — | — | US | disclosed |
| EP-2621939-A1 | FUNCTIONALIZED FLUOROALKYL FLUOROPHOSPHATE SALTS | Merck Patent GmbH (DE) | 2013-08-07 | — | — | EP | disclosed |
| US-20130197228-A1 | FUNCTIONALIZED FLUOROALKYL FLUOROPHOSPHATE SALTS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2013-08-01 | — | — | US | disclosed |
| CN-103124736-A | Functionalized fluoroalkyl fluorophosphate salts | MERCK PATENT GMBH | 2013-05-29 | — | — | CN | disclosed |
| CN-103073500-A | Rare earth metal ionic liquid, preparation method and application thereof | UNIV SICHUAN | 2013-05-01 | — | — | CN | disclosed |
| WO-2012048772-A1 | FUNCTIONALIZED FLUOROALKYL FLUOROPHOSPHATE SALTS | MERCK PATENT GMBH (DE) | 2012-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10160777-B2 | Alkenyl(perfluoroalkyl)phosphinic acids | PHOSPHO1, PFAS, SLCO4C1 | ALDH1A1 4088/4885PKM 643/4885POLB 2973/4885 |
| US-20170240574-A1 | ALKENYL (PERFLUOROALKYL) PHOSPHINIC ACIDS | PHOSPHO1, PFAS, SLCO4C1 | ALDH1A1 4088/4885PKM 643/4885POLB 2973/4885 |
| US-20130197228-A1 | FUNCTIONALIZED FLUOROALKYL FLUOROPHOSPHATE SALTS | INPPL1, INPP5D, PLCB3 | ALDH1A1 2122/4885PKM 3517/4885POLB 2402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.